New Delhi/Lucknow: The Central Government has taken a very relief decision for lakhs of patients and their families suffering from joint pain and arthritis across the country. The National Pharmaceutical Pricing Authority (NPPA) has extended the deadline for ceiling prices of orthopedic knee implants used in knee replacement systems. According to the official notification issued by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, the controlled rates of knee implants will now be effective till January 15, 2027. It is noteworthy that under the order (SO 5190(E)) issued earlier in November 2025, the validity of these prices was going to end on 15 November 2026. This decision taken by the government just before the end of the deadline has ensured that no hospital or medical device company will be able to charge arbitrary prices from patients in the coming months. Price control system is in effect from August 2017, patients are saving thousands of rupees. Due to increasing cases of Osteoarthritis among elderly and middle-aged people in India, the demand for knee replacement surgery is continuously increasing. Before 2017, private hospitals and implant manufacturers used to charge patients Rs 1.5 lakh to Rs 3 lakh for implants of different metals and brands. To save the general public from this huge financial burden, the Central Government had for the first time issued a notification (SO 2668(E)) on 16 August 2017 under Para 19 of the Drugs (Price Control) Order, 2013 (DPCO, 2013), setting the maximum limit on the prices of knee implants. After this historic step of the government, there was a huge decline in the prices of implants by about 65 to 70 percent. In the latest order, NPPA has clarified that all the provisions and conditions of the original notification dated 16 August 2017 will remain applicable without any change till 15 January 2027. From Cobalt Chromium to Titanium implants, maximum retail prices are fixed. Under the price control system of NPPA, separate prices are fixed for all the major components used in Primary Knee Replacement and Revision Knee Replacement such as Femoral Component, Tibial Tray, Articulating Insert and Patella. The government has set clear ceiling prices for implants made from simple Cobalt Chromium implant systems to high quality titanium alloy and special metals like Oxidized Zirconium. This forces hospitals to maintain transparency during billing and they cannot charge more by hiding the price of the implant in the name of the package. Recently also in September 2026, NPPA had directed all implant manufacturers and importers to mandatorily submit complete data of their production, import and market share on the IPDMS 2.0 portal so that no artificial shortage of any kind is created in the market. Strict action will be taken against hospitals breaking the rules, complain about overcharging here. The National Drug Pricing Authority has issued a stern warning to all the hospitals, distributors and medical device sellers that charging even one rupee more than the prescribed maximum price will be considered a direct violation of the provisions of DPCO, 2013 (DPCO, 2013). If any hospital or seller asks for more money than the fixed price or denies availability of the implant, legal action will be taken against them for overcharging and the excess amount recovered will have to be refunded along with interest. If any patient or attendant faces such a problem in any city of the country including Lucknow, Kanpur, Varanasi, Noida and Prayagraj in Uttar Pradesh, they can immediately call NPPA's toll-free helpline number 1800-111-255 or register their complaint through 'Pharma Sahi Daam' mobile app and portal. Before undergoing surgery, patients must demand the type of implant and its itemized bill from the hospital so that they can take full advantage of the government discount.
